ATE164578T1 - Verzweigte aminothiazole-derivate, verfahren zu ihrer herstellung und pharmazeutische zusammenstellungen die sie enthalten - Google Patents
Verzweigte aminothiazole-derivate, verfahren zu ihrer herstellung und pharmazeutische zusammenstellungen die sie enthaltenInfo
- Publication number
- ATE164578T1 ATE164578T1 AT94402954T AT94402954T ATE164578T1 AT E164578 T1 ATE164578 T1 AT E164578T1 AT 94402954 T AT94402954 T AT 94402954T AT 94402954 T AT94402954 T AT 94402954T AT E164578 T1 ATE164578 T1 AT E164578T1
- Authority
- AT
- Austria
- Prior art keywords
- branched
- production
- pharmaceutical compositions
- compositions containing
- aminothiazole derivatives
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D277/38—Nitrogen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D277/38—Nitrogen atoms
- C07D277/42—Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Immunology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Transplantation (AREA)
- Anesthesiology (AREA)
- Psychiatry (AREA)
- Urology & Nephrology (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Thiazole And Isothizaole Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR9315386A FR2714059B1 (fr) | 1993-12-21 | 1993-12-21 | Dérivés amino ramifiés du thiazole, leurs procédés de préparation et les compositions pharmaceutiques qui les contiennent. |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE164578T1 true ATE164578T1 (de) | 1998-04-15 |
Family
ID=9454174
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT94402954T ATE164578T1 (de) | 1993-12-21 | 1994-12-20 | Verzweigte aminothiazole-derivate, verfahren zu ihrer herstellung und pharmazeutische zusammenstellungen die sie enthalten |
Country Status (23)
| Country | Link |
|---|---|
| US (2) | US5602132A (de) |
| EP (1) | EP0659747B1 (de) |
| JP (1) | JP3022223B2 (de) |
| KR (1) | KR950017980A (de) |
| CN (1) | CN1058964C (de) |
| AT (1) | ATE164578T1 (de) |
| AU (1) | AU685876B2 (de) |
| CA (1) | CA2138638A1 (de) |
| CZ (1) | CZ323094A3 (de) |
| DE (1) | DE69409337T2 (de) |
| DK (1) | DK0659747T3 (de) |
| ES (1) | ES2115904T3 (de) |
| FI (1) | FI945975A (de) |
| FR (1) | FR2714059B1 (de) |
| HU (1) | HUT71103A (de) |
| IL (1) | IL112074A (de) |
| NO (1) | NO304598B1 (de) |
| NZ (1) | NZ270229A (de) |
| PL (1) | PL306402A1 (de) |
| RU (1) | RU2107063C1 (de) |
| SI (1) | SI0659747T1 (de) |
| TW (1) | TW401410B (de) |
| ZA (1) | ZA9410196B (de) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5795905A (en) * | 1995-06-06 | 1998-08-18 | Neurocrine Biosciences, Inc. | CRF receptor antagonists and methods relating thereto |
| FR2754258B1 (fr) * | 1996-10-08 | 1998-12-31 | Sanofi Sa | Derives d'aminothiazole, leur procede de preparation et les compositions pharmaceutiques les contenant |
| FR2796380B3 (fr) | 1999-07-15 | 2001-08-17 | Sanofi Synthelabo | Nouveaux derives d'aminothiazoles, leur preparation et les compositions pharmaceutiques les contenant |
| TWI271406B (en) | 1999-12-13 | 2007-01-21 | Eisai Co Ltd | Tricyclic condensed heterocyclic compounds, preparation method of the same and pharmaceuticals comprising the same |
| KR20030016222A (ko) * | 2000-02-14 | 2003-02-26 | 니뽄 다바코 산교 가부시키가이샤 | 수술후 스트레스 예방ㆍ치료제 |
| EP1149583A3 (de) * | 2000-04-13 | 2001-11-14 | Pfizer Products Inc. | Kombinationen bestehend aus Antagonisten des Corticotropin freisetzenden Faktors und Stoffen, die die Wachstumshormonsekretion fördern |
| HUP0303038A2 (hu) * | 2000-09-21 | 2003-12-29 | Bristol-Myers Squibb Co. | Szubsztituált azolszármazékok mint kortikotropin releasing faktor inhibitorok, ezeket tartalmazó gyógyszerkészítmények és alkalmazásuk |
| TWI312347B (en) | 2001-02-08 | 2009-07-21 | Eisai R&D Man Co Ltd | Bicyclic nitrogen-containing condensed ring compounds |
| AU2002314744A1 (en) | 2001-04-17 | 2002-10-28 | Sepracor, Inc. | Thiazole and other heterocyclic ligands and use thereof |
| EP1389618B1 (de) | 2001-04-27 | 2011-06-15 | Eisai R&D Management Co., Ltd. | Pyrazolo 1,5-a pyridine und diese enthaltende arzneimittel |
| EP1285914B1 (de) * | 2001-08-13 | 2007-12-19 | PheneX Pharmaceuticals AG | Nr1h4-kern-rezeptor-bindende verbindungen |
| EP1423113A4 (de) * | 2001-08-13 | 2007-04-18 | Phenex Pharmaceuticals Ag | Nr1h4-nuklearrezeptorbindende verbindungen |
| CA2496618A1 (en) * | 2002-05-23 | 2003-12-04 | Michael Holick | Use of a parathyroid hormone peptide analogs for the treatment of vaginal atrophy |
| US7176216B2 (en) | 2002-10-22 | 2007-02-13 | Eisai Co., Ltd. | 7-phenylpyrazolopyridine compounds |
| AU2003275589B2 (en) | 2002-10-22 | 2009-05-28 | Eisai R & D Management Co., Ltd. | 7-phenyl pyrazolopyridine compounds |
| CA2721670C (en) | 2008-04-15 | 2013-09-10 | Eisai R&D Management Co., Ltd. | 3-phenylpyrazolo[5,1-b]thiazole compound |
| AR078521A1 (es) | 2009-10-08 | 2011-11-16 | Eisai R&D Man Co Ltd | Compuesto pirazolotiazol |
| WO2011043387A1 (ja) * | 2009-10-08 | 2011-04-14 | エーザイ・アール・アンド・ディー・マネジメント株式会社 | ピラゾロオキサゾール化合物 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3299087A (en) * | 1961-04-24 | 1967-01-17 | Geigy Chem Corp | Nu, nu'-bis-(thiazolyl)-phenylenediamines |
| US5232921A (en) * | 1987-03-12 | 1993-08-03 | Sanofi | Thiazole derivatives active on the cholinergic system, process for obtention and pharmaceutical compositions |
| FR2612187B1 (fr) * | 1987-03-12 | 1989-07-21 | Sanofi Sa | Derives du thiazole actifs sur le systeme cholinergique, leur procede de preparation et compositions pharmaceutiques en contenant |
| DE3923675A1 (de) * | 1989-07-18 | 1991-01-24 | Basf Ag | Amonoalkylsubstituierte 2-aminothiazole und diese enthaltende therapeutische mittel |
| FR2656610B1 (fr) * | 1989-12-29 | 1992-05-07 | Sanofi Sa | Derives d'amino-2 phenyl-4 thiazole, leur procede de preparation et leur application therapeutique. |
| FR2692893B1 (fr) * | 1992-06-24 | 1994-09-02 | Sanofi Elf | Dérivés alkylamino ramifiés du thiazole, leurs procédés de préparation et les compositions pharmaceutiques qui les contiennent. |
-
1993
- 1993-12-21 FR FR9315386A patent/FR2714059B1/fr not_active Expired - Fee Related
-
1994
- 1994-12-19 TW TW083111880A patent/TW401410B/zh active
- 1994-12-19 CZ CZ943230A patent/CZ323094A3/cs unknown
- 1994-12-20 FI FI945975A patent/FI945975A/fi unknown
- 1994-12-20 DK DK94402954T patent/DK0659747T3/da active
- 1994-12-20 CA CA002138638A patent/CA2138638A1/en not_active Abandoned
- 1994-12-20 AU AU81632/94A patent/AU685876B2/en not_active Ceased
- 1994-12-20 IL IL11207494A patent/IL112074A/en not_active IP Right Cessation
- 1994-12-20 RU RU94044534A patent/RU2107063C1/ru active
- 1994-12-20 SI SI9430138T patent/SI0659747T1/xx unknown
- 1994-12-20 EP EP94402954A patent/EP0659747B1/de not_active Expired - Lifetime
- 1994-12-20 PL PL94306402A patent/PL306402A1/xx unknown
- 1994-12-20 NO NO944946A patent/NO304598B1/no not_active IP Right Cessation
- 1994-12-20 DE DE69409337T patent/DE69409337T2/de not_active Expired - Fee Related
- 1994-12-20 JP JP6316765A patent/JP3022223B2/ja not_active Expired - Lifetime
- 1994-12-20 ES ES94402954T patent/ES2115904T3/es not_active Expired - Lifetime
- 1994-12-20 AT AT94402954T patent/ATE164578T1/de active
- 1994-12-20 HU HU9403690A patent/HUT71103A/hu unknown
- 1994-12-21 KR KR1019940035536A patent/KR950017980A/ko active IP Right Grant
- 1994-12-21 NZ NZ270229A patent/NZ270229A/en unknown
- 1994-12-21 CN CN94119558A patent/CN1058964C/zh not_active Expired - Fee Related
- 1994-12-21 ZA ZA9410196A patent/ZA9410196B/xx unknown
- 1994-12-21 US US08/360,351 patent/US5602132A/en not_active Expired - Fee Related
-
1996
- 1996-11-27 US US08/756,402 patent/US5821255A/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| CZ323094A3 (en) | 1995-07-12 |
| HU9403690D0 (en) | 1995-02-28 |
| FI945975A0 (fi) | 1994-12-20 |
| US5821255A (en) | 1998-10-13 |
| HUT71103A (en) | 1995-11-28 |
| EP0659747B1 (de) | 1998-04-01 |
| FR2714059B1 (fr) | 1996-03-08 |
| DE69409337T2 (de) | 1998-10-08 |
| RU2107063C1 (ru) | 1998-03-20 |
| JP3022223B2 (ja) | 2000-03-15 |
| CA2138638A1 (en) | 1995-06-22 |
| PL306402A1 (en) | 1995-06-26 |
| KR950017980A (ko) | 1995-07-22 |
| AU685876B2 (en) | 1998-01-29 |
| ES2115904T3 (es) | 1998-07-01 |
| CN1058964C (zh) | 2000-11-29 |
| NZ270229A (en) | 1996-04-26 |
| DK0659747T3 (da) | 1999-01-11 |
| EP0659747A1 (de) | 1995-06-28 |
| TW401410B (en) | 2000-08-11 |
| NO944946D0 (no) | 1994-12-20 |
| SI0659747T1 (en) | 1998-08-31 |
| IL112074A0 (en) | 1995-03-15 |
| US5602132A (en) | 1997-02-11 |
| FI945975A (fi) | 1995-06-22 |
| FR2714059A1 (fr) | 1995-06-23 |
| DE69409337D1 (de) | 1998-05-07 |
| ZA9410196B (en) | 1996-06-21 |
| IL112074A (en) | 1998-12-06 |
| RU94044534A (ru) | 1996-10-27 |
| NO304598B1 (no) | 1999-01-18 |
| CN1127252A (zh) | 1996-07-24 |
| JPH07224051A (ja) | 1995-08-22 |
| AU8163294A (en) | 1995-06-29 |
| NO944946L (no) | 1995-06-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE164578T1 (de) | Verzweigte aminothiazole-derivate, verfahren zu ihrer herstellung und pharmazeutische zusammenstellungen die sie enthalten | |
| ATE128143T1 (de) | 17-beta-substituierte-4-aza-5-alpha-androstan-3 one-derivate und verfahren zu ihrer herstellung. | |
| ATE129503T1 (de) | Amidinophenylalaninderivate, verfahren zu deren herstellung, deren verwendung und diese enthaltende mittel als antikoagulantien. | |
| ATE122035T1 (de) | Naphthylethylharnstoff und naphthylethylthioharnstoff verbindungen, verfahren zu ihrer herstellung und pharmazeutische zusammensetzungen, die sie enthalten. | |
| ATE145904T1 (de) | Isochinolin-5-yl-sulfonsäureamide, verfahren zu ihrer herstellung und pharmazeutische zusammensetzungen, die sie enthalten | |
| ATE174920T1 (de) | Pyridothiadiazine, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische zusammensetzungen | |
| NO933200L (no) | Substituerte cykloheksanderivater, fremgangsmåte til fremstilling derav og anvendelsen av forbindelsene til behandling av sykdommer | |
| ATE211474T1 (de) | Galanthamin derivate, verfahren zu ihrer herstellung und ihre verwendung als medikamente | |
| DE59102986D1 (de) | Heterocyclisch substituierte Dihydropyridine, Verfahren zu ihrer Herstellung und ihre Verwendung in Arzneimitteln. | |
| ATE17727T1 (de) | Alkylenverbrueckte guanidinothiazolderivate, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel. | |
| ATE193531T1 (de) | Phenyl-carboxamide-isoxazole-derivate und salze, verfahren zu ihrer herstellung ihre anwendung als arzneimittel und pharmazeutische zusammensetzungen die sie enthalten | |
| HUT46664A (en) | Process for producing new dihydropyridineamide derivatives and pharmaceutical compositions comprising these compounds | |
| ATE172976T1 (de) | 3-aminochroman-spiroderivate, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzungen | |
| ATE73785T1 (de) | 5-(3-alkyl-5-tert.butyl-4-hydroxyphenyl)-2-amin - 6h-1,3,4-thiadiazine, verfahren zu ihrer herstellung, die sie enthaltenden arzneimittel und ihre verwendung. | |
| ATE2794T1 (de) | 1-n-alkylsisomicin-derivate, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel. | |
| ATE102924T1 (de) | 1-(4-aminophenyl)-2-piperidinopropanon-derivate verfahren zu deren herstellung und therapeutische verwendung. | |
| ATE170520T1 (de) | Eburnan-derivate, verfahren zur ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen | |
| ATE59035T1 (de) | Basisch substituierte benzofurancarbonsaeureamide, verfahren zu ihrer herstellung und sie enthaltende therapeutische mittel. | |
| ATE113598T1 (de) | Substituierte vinylcephalosporine, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel. | |
| ATE193703T1 (de) | N-benzylpiperazinverbindungen, verfahren zu ihrer herstellung und sie enthaltende zusammensetzungen | |
| ES2062214T3 (es) | Derivados de aminooligohidroxi inhibidores de renina. | |
| ATE14124T1 (de) | Ringfoermige sulfenamide, verfahren zu ihrer herstellung, sie enthaltende arzneimittel und deren herstellung. | |
| ATE87002T1 (de) | Substituierte 3-phenyl-7h-thiazolo(3,2 -b> (1,2,4>triazin-7-one, verfahren zu ihrer herstellung, die sie enthaltenden arzneimittel und ihre verwendung, sowie einige bei der herstellung der genannten verbindungen gebildete zwischenprodukte. | |
| ATE12390T1 (de) | Basisch substituierte anthranilsaeuren, verfahren zu ihrer herstellung und ihre verwendung. | |
| ATE24718T1 (de) | Alkylcycloalkyl-imidazolylmethyl-ketone und verfahren zu ihrer herstellung. |